Gene · 11096
Papers3,260
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,260
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ADAMTS Proteases: Their Multifaceted Role in the Regulation of Cancer Metastasis. | Dis Res | 2024 | 38948119 | PubTator, text mining | PubMed |
| SP1‑mediated ADAMTS5 transcription promotes IL‑1β‑induced chondrocyte injury via Wnt/β‑catenin pathway in osteoarthritis. | Mol Med Rep | 2024 | 38940327 | PubTator, text mining | PubMed |
| Time-Dependent Effect of Eggshell Membrane on Monosodium-Iodoacetate-Induced Osteoarthritis: Early-Stage Inflammation Control and Late-Stage Cartilage Protection. | Nutrients | 2024 | 38931240 | PubTator, text mining | PubMed |
| Luteolin regulating synthesis and catabolism of osteoarthritis chondrocytes via activating autophagy. | Heliyon | 2024 | 38882274 | PubTator, text mining | PubMed |
| Serum ARGS-aggrecan in a phase 2 clinical trial targeting osteoarthritis. | Osteoarthritis Cartilage | 2024 | 38862084 | PubTator, text mining | PubMed |
| Sappanone a alleviates osteoarthritis progression by inhibiting chondrocyte ferroptosis via activating the SIRT1/Nrf2 signaling pathway. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | 38832987 | PubTator, text mining | PubMed |
| Growth hormone-receptor disruption in mice reduces osteoarthritis and chondrocyte hypertrophy. | Geroscience | 2024 | 38831184 | PubTator, text mining | PubMed |
| Identification and validation of the TRHDE-AS1/hsa-miR-449a/ADAMTS5 axis as a novel prognostic biomarker in prostate cancer. | Biofactors | 2024 | 38818922 | PubTator, text mining | PubMed |
| Exploring shared molecular signatures and regulatory mechanisms in nonalcoholic steatohepatitis and inflammatory bowel disease using integrative bioinformatics analysis. | Sci Rep | 2024 | 38802459 | PubTator, text mining | PubMed |
| Autoreactivity to self-antigens LL37 and ADAMTSL5 influences the clinical response to risankizumab in psoriatic patients. | J Autoimmun | 2024 | 38797050 | PubTator, text mining | PubMed |
| Bio-nanoparticles loaded with synovial-derived exosomes ameliorate osteoarthritis progression by modifying the oxidative microenvironment. | J Nanobiotechnology | 2024 | 38769545 | PubTator, text mining | PubMed |
| Identification of a novel matrix metalloproteinases-related prognostic signature in hepatocellular carcinoma. | Aging (Albany NY) | 2024 | 38761174 | PubTator, text mining | PubMed |
| Predicting Injuries in Elite Female Football Players With Global-Positioning-System and Multiomics Data. | Int J Sports Physiol Perform | 2024 | 38753297 | PubTator, text mining | PubMed |
| Activation of Notch Signaling Pathway is involved in Extracellular Matrix Degradation in human induced pluripotent stem cells chondrocytes induced by HT-2 toxin. | Food Chem Toxicol | 2024 | 38734200 | PubTator, text mining | PubMed |
| New therapeutic strategies in osteoarthritis. | Joint Bone Spine | 2024 | 38685527 | PubTator, text mining | PubMed |
| The Genetic Markers of Knee Osteoarthritis in Women from Russia. | Biomedicines | 2024 | 38672138 | PubTator, text mining | PubMed |
| Human Infrapatellar Fat Pad Mesenchymal Stem Cell-derived Extracellular Vesicles Purified by Anion Exchange Chromatography Suppress Osteoarthritis Progression in a Mouse Model. | Clin Orthop Relat Res | 2024 | 38662932 | PubTator, text mining | PubMed |
| Icariin inhibits chondrocyte ferroptosis and alleviates osteoarthritis by enhancing the SLC7A11/GPX4 signaling. | Int Immunopharmacol | 2024 | 38636375 | PubTator, text mining | PubMed |
| An exosome mRNA-related gene risk model to evaluate the tumor microenvironment and predict prognosis in hepatocellular carcinoma. | BMC Med Genomics | 2024 | 38627727 | PubTator, text mining | PubMed |
| A hypoxia-glycolysis-lactate-related gene signature for prognosis prediction in hepatocellular carcinoma. | BMC Med Genomics | 2024 | 38627714 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11096/papers?page=10